Loading asset research
Armata Pharmaceuticals Inc. Common Stock
ARMPNYSE · USD · StocksQuote as of · Exchange session not verified$5.38
+2.87%
Today
ARMP
Loading 1D prices…
Market cap
$200M
Volume
43.6K
52w high
$16.3452w low
$2.86Company profile
Armata Pharmaceuticals Inc. Common Stock
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
NYSE
Display currency
USD
Location
Los Angeles, CA, United States
Employees
61
Fiscal year end
1231
CIK
921114
Session & valuation
Open$5.30
Previous close$5.23
Day high$5.55
Day low$5.26
30-day avg. volume96.3K
Outstanding shares37.2M
Diluted EPS-$4.80
Latest annual period
P/E (trailing)-1.12
P/E (forward)-3.43
Price / book-0.86
Beta1.35
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| DTILPrecision BioSciences Inc. Common Stock | $197.9M | $34.3M | -133.45% | -$3.56 | -0.97% | Buy |
| VYGRVoyager Therapeutics Inc. Common Stock | $196.6M | $40.4M | -296.53% | -$2.04 | 0.00% | Buy |
| NMRANeumora Therapeutics Inc. Common Stock | $195.4M | $0.00 | — | -$1.45 | -9.21% | Buy |
| CHRSCoherus Oncology Inc. Common Stock | $205.5M | $42.2M | +398.43% | $1.43 | +0.00% | Buy |
| ACOGAlpha Cognition Inc. Common Stock | $193.8M | $10.2M | -202.24% | -$1.18 | 0.00% | Buy |